ghk cu injection australia GHK-Cu 100mg Copper Tripeptide | COA GHK-Cu 50mg Research Peptide Australia

Composition GHK-Cu (Copper Tripeptide-1): 50 mg BPC-157 (Body Protection Compound-157): 10 mg TB-500 (synthetic fragment associated with Thymosin Beta-4): 10 mg Total content: 70 mg Form: Lyophilized powder Purity: 98% (each component) Technical Characteristics Type: Synthetic peptide combination Regulatory status: Research Use Only (RUO) Classification: Not intended for clinical, therapeutic, or diagnostic use Each batch undergoes rigorous quality control to ensure identity, purity, and consistency for scientific research applications

Para continuar, ingresa atu cuenta trace-id: 10a65fe5-9e4d-4ec8-821b-da4953b85322 Usamos cookies para mejorar tu experiencia en Mercado Libre

Maria H

Primary outcome is 1 year OS

Wenn die Zeit zwischen der Anwendung des stressreduzierenden Mittels und der Stressauslsung (im folgenden Text als Zeitraum bezeichnet) verlngert wird, werden die ulkushemmenden Standardmittel praktisch unwirksam, was der eindeutigen Wirksamkeit des getesteten NaBPC157 stark widerspricht